Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1714010

registered interest
date	25/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Prescription Drugs: Shortages
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what assessment they have made of shortages in the supply of prescription drugs.
tabling member printed	The Lord Bishop of Southwark
uin	HL4117
answer	answer is ministerial correction date of answer 30/04/2024 answer text <p>There are approximately 14,000 medicines licensed for supply in the United Kingdom, and the overwhelming majority are in good supply. The medicine supply chain is complex, global, and highly regulated, and supply issues can be caused by a range of factors. For example, suppliers can encounter manufacturing problems, difficulty accessing raw materials, and surges in demand. These are commonly cited as the drivers of the recent supply issues, which have affected many countries, not just the UK.</p><p>Whilst we can’t always prevent supply issues, we have a range of well-established tools and processes to mitigate risks to patients. These include close and regular engagement with suppliers, use of alternative strengths or forms of a medicine to allow patients to remain on the same product, expediting regulatory procedures, sourcing unlicensed imports from abroad, adding products to the restricted exports and hoarding list, use of Serious Shortage Protocols, and issuing National Health Service communications to provide management advice and information on the issue to healthcare professionals, so they can advise and support their patients.</p> answering member printed Lord Markham question first answered 30/04/2024 11:37:26 answering member 4948 label Biography information for Lord Markham
tabling member	4345 label Biography information for The Lord Bishop of Southwark

1713721

registered interest
date	24/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Aviation: Medical Equipment
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what assessment they have made of operation of law in relation to the provision of adrenaline auto-injectors on commercial aircraft.
tabling member printed	Lord Kennedy of Southwark
uin	HL4071
answer	answer is ministerial correction date of answer 30/04/2024 answer text <p>Following their review, the Adrenaline Auto-injector Expert Working Group (AAI EWG) recommended in principle that adrenaline auto-injectors (AAIs) should be made available in public locations, for use in treating anaphylaxis in unforeseen and critical circumstances, provided suitable safeguards can be implemented to ensure their effective and safe use. Challenges lie in ensuring correct and secure storage of AAIs, to ensure that the adrenaline does not deteriorate, and the device remains functional. Cinemas offering food for sale and other food outlets were identified as examples of locations where emergency AAIs might have particular potential to save lives.</p><p>The legislative change will therefore concern AAI supply, to specify or define individuals or organisations with the necessary competence to obtain and store AAIs for use in the event of an anaphylactic emergency. The AAI EWG advised the need for access to AAIs in a broad range of settings such as restaurants, gyms, cinemas, childcare facilities, youth groups, and music festivals. To support such wide-ranging access, the scope of legal supply will need to be linked to a requirement for training, to support safe use.</p><p>An Expert Advisory Group for Allergy was established in 2023, across the Government and clinical organisations, and chaired by the National Allergy Strategy Group and the Department, to recommend further action by the Medicines and Healthcare products Regulatory Agency (MHRA), Department of Health and Social Care, Department for Education, and the National Health Service. The Department of Health and Social Care and the MHRA are currently considering updates to the 2017 guidance, to ensure that any updated clarifications are supported by evidence, and that any open questions are answered.</p> answering member printed Lord Markham grouped question UIN HL4072 HL4073 HL4074 question first answered 30/04/2024 11:25:28 answering member 4948 label Biography information for Lord Markham
tabling member	4153 label Biography information for Lord Kennedy of Southwark

1713722

registered interest
date	24/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Adrenaline: Medical Equipment
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what assessment they have made of operation of law in relation to the provision of adrenaline auto-injectors on trains.
tabling member printed	Lord Kennedy of Southwark
uin	HL4072
answer	answer is ministerial correction date of answer 30/04/2024 answer text <p>Following their review, the Adrenaline Auto-injector Expert Working Group (AAI EWG) recommended in principle that adrenaline auto-injectors (AAIs) should be made available in public locations, for use in treating anaphylaxis in unforeseen and critical circumstances, provided suitable safeguards can be implemented to ensure their effective and safe use. Challenges lie in ensuring correct and secure storage of AAIs, to ensure that the adrenaline does not deteriorate, and the device remains functional. Cinemas offering food for sale and other food outlets were identified as examples of locations where emergency AAIs might have particular potential to save lives.</p><p>The legislative change will therefore concern AAI supply, to specify or define individuals or organisations with the necessary competence to obtain and store AAIs for use in the event of an anaphylactic emergency. The AAI EWG advised the need for access to AAIs in a broad range of settings such as restaurants, gyms, cinemas, childcare facilities, youth groups, and music festivals. To support such wide-ranging access, the scope of legal supply will need to be linked to a requirement for training, to support safe use.</p><p>An Expert Advisory Group for Allergy was established in 2023, across the Government and clinical organisations, and chaired by the National Allergy Strategy Group and the Department, to recommend further action by the Medicines and Healthcare products Regulatory Agency (MHRA), Department of Health and Social Care, Department for Education, and the National Health Service. The Department of Health and Social Care and the MHRA are currently considering updates to the 2017 guidance, to ensure that any updated clarifications are supported by evidence, and that any open questions are answered.</p> answering member printed Lord Markham grouped question UIN HL4071 HL4073 HL4074 question first answered 30/04/2024 11:25:28 answering member 4948 label Biography information for Lord Markham
tabling member	4153 label Biography information for Lord Kennedy of Southwark

1713723

registered interest
date	24/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Aviation: Medical Equipment
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what requirements there are for airlines to ensure adrenaline auto-injectors are available on commercial flights.
tabling member printed	Lord Kennedy of Southwark
uin	HL4073
answer	answer is ministerial correction date of answer 30/04/2024 answer text <p>Following their review, the Adrenaline Auto-injector Expert Working Group (AAI EWG) recommended in principle that adrenaline auto-injectors (AAIs) should be made available in public locations, for use in treating anaphylaxis in unforeseen and critical circumstances, provided suitable safeguards can be implemented to ensure their effective and safe use. Challenges lie in ensuring correct and secure storage of AAIs, to ensure that the adrenaline does not deteriorate, and the device remains functional. Cinemas offering food for sale and other food outlets were identified as examples of locations where emergency AAIs might have particular potential to save lives.</p><p>The legislative change will therefore concern AAI supply, to specify or define individuals or organisations with the necessary competence to obtain and store AAIs for use in the event of an anaphylactic emergency. The AAI EWG advised the need for access to AAIs in a broad range of settings such as restaurants, gyms, cinemas, childcare facilities, youth groups, and music festivals. To support such wide-ranging access, the scope of legal supply will need to be linked to a requirement for training, to support safe use.</p><p>An Expert Advisory Group for Allergy was established in 2023, across the Government and clinical organisations, and chaired by the National Allergy Strategy Group and the Department, to recommend further action by the Medicines and Healthcare products Regulatory Agency (MHRA), Department of Health and Social Care, Department for Education, and the National Health Service. The Department of Health and Social Care and the MHRA are currently considering updates to the 2017 guidance, to ensure that any updated clarifications are supported by evidence, and that any open questions are answered.</p> answering member printed Lord Markham grouped question UIN HL4071 HL4072 HL4074 question first answered 30/04/2024 11:25:28 answering member 4948 label Biography information for Lord Markham
tabling member	4153 label Biography information for Lord Kennedy of Southwark

1713724

registered interest
date	24/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Airports: Medical Equipment
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what requirements there are for airports to ensure adrenaline auto-injectors are available on their premises.
tabling member printed	Lord Kennedy of Southwark
uin	HL4074
answer	answer is ministerial correction date of answer 30/04/2024 answer text <p>Following their review, the Adrenaline Auto-injector Expert Working Group (AAI EWG) recommended in principle that adrenaline auto-injectors (AAIs) should be made available in public locations, for use in treating anaphylaxis in unforeseen and critical circumstances, provided suitable safeguards can be implemented to ensure their effective and safe use. Challenges lie in ensuring correct and secure storage of AAIs, to ensure that the adrenaline does not deteriorate, and the device remains functional. Cinemas offering food for sale and other food outlets were identified as examples of locations where emergency AAIs might have particular potential to save lives.</p><p>The legislative change will therefore concern AAI supply, to specify or define individuals or organisations with the necessary competence to obtain and store AAIs for use in the event of an anaphylactic emergency. The AAI EWG advised the need for access to AAIs in a broad range of settings such as restaurants, gyms, cinemas, childcare facilities, youth groups, and music festivals. To support such wide-ranging access, the scope of legal supply will need to be linked to a requirement for training, to support safe use.</p><p>An Expert Advisory Group for Allergy was established in 2023, across the Government and clinical organisations, and chaired by the National Allergy Strategy Group and the Department, to recommend further action by the Medicines and Healthcare products Regulatory Agency (MHRA), Department of Health and Social Care, Department for Education, and the National Health Service. The Department of Health and Social Care and the MHRA are currently considering updates to the 2017 guidance, to ensure that any updated clarifications are supported by evidence, and that any open questions are answered.</p> answering member printed Lord Markham grouped question UIN HL4071 HL4072 HL4073 question first answered 30/04/2024 11:25:28 answering member 4948 label Biography information for Lord Markham
tabling member	4153 label Biography information for Lord Kennedy of Southwark

1713725

registered interest
date	24/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	First Aid: Adrenaline
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what guidance they have issued on the administering of adrenaline auto-injectors by minors in medical emergencies.
tabling member printed	Lord Kennedy of Southwark
uin	HL4075
answer	answer is ministerial correction date of answer 30/04/2024 answer text <p>The Medicines and Healthcare products Regulatory Agency (MHRA) has published guidance on the use of adrenaline auto-injectors in schools, and there is provision in this guidance for the use of an adrenaline auto-injector on someone to whom it was not prescribed, in a medical emergency. However, regulation 238 of the Human Medicines Regulations 2012 provides an exemption from certain requirements related to the administration of medicines. Specifically, it allows for parenteral, rather than injected or absorbed, administration of specified medicines in emergency situations, where the purpose is to save a life. For instance, adrenaline prescribed for a specific person, or even to an unknown person, can be administered under this regulation, if it is necessary to save a life during an emergency. The use in emergencies is covered by schedule 19 and regulation 238, where age is not specified.</p><p>An Expert Advisory Group for Allergy was established in 2023, across the Government and clinical organisations, and chaired by the National Allergy Strategy Group and the Department, to recommend further action by the MHRA, Department of Health and Social Care, Department for Education, and the National Health Service. The Department of Health and Social Care and the MHRA are currently considering updates to the 2017 guidance, to ensure that any updated clarifications are supported by evidence, and that any open questions are answered.</p> answering member printed Lord Markham grouped question UIN HL4076 question first answered 30/04/2024 11:36:16 answering member 4948 label Biography information for Lord Markham
tabling member	4153 label Biography information for Lord Kennedy of Southwark

1713726

registered interest
date	24/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	First Aid: Adrenaline
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what guidance they have issued regarding the use of an adrenaline auto-injector on someone to whom it was not prescribed in a medical emergency.
tabling member printed	Lord Kennedy of Southwark
uin	HL4076
answer	answer is ministerial correction date of answer 30/04/2024 answer text <p>The Medicines and Healthcare products Regulatory Agency (MHRA) has published guidance on the use of adrenaline auto-injectors in schools, and there is provision in this guidance for the use of an adrenaline auto-injector on someone to whom it was not prescribed, in a medical emergency. However, regulation 238 of the Human Medicines Regulations 2012 provides an exemption from certain requirements related to the administration of medicines. Specifically, it allows for parenteral, rather than injected or absorbed, administration of specified medicines in emergency situations, where the purpose is to save a life. For instance, adrenaline prescribed for a specific person, or even to an unknown person, can be administered under this regulation, if it is necessary to save a life during an emergency. The use in emergencies is covered by schedule 19 and regulation 238, where age is not specified.</p><p>An Expert Advisory Group for Allergy was established in 2023, across the Government and clinical organisations, and chaired by the National Allergy Strategy Group and the Department, to recommend further action by the MHRA, Department of Health and Social Care, Department for Education, and the National Health Service. The Department of Health and Social Care and the MHRA are currently considering updates to the 2017 guidance, to ensure that any updated clarifications are supported by evidence, and that any open questions are answered.</p> answering member printed Lord Markham grouped question UIN HL4075 question first answered 30/04/2024 11:36:16 answering member 4948 label Biography information for Lord Markham
tabling member	4153 label Biography information for Lord Kennedy of Southwark

1713279

registered interest
date	23/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Professions: Regulation
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what progress they have made towards the new regulatory system for health and care professionals; and which protected professional titles they are considering in scope of these regulations.
tabling member printed	Baroness Bennett of Manor Castle
uin	HL4020
answer	answer is ministerial correction date of answer 30/04/2024 answer text <p>The Anaesthesia Associates and Physician Associates Order 2024 was made on 13 March 2024 which will bring anaesthesia associates and physician associates into regulation by the General Medical Council under a reformed regulatory framework. We are currently working on the next phase of reform, which will introduce a new regulatory framework for medical practitioners and the professions regulated by the Nursing and Midwifery Council and the Health and Care Professions Council.</p><p>As part of the Government’s regulatory reform programme, protected titles will be considered more broadly, as we take forward legislation for each regulator.</p> answering member printed Lord Markham question first answered 30/04/2024 16:54:38 answering member 4948 label Biography information for Lord Markham
tabling member	4719 label Biography information for Baroness Bennett of Manor Castle